| scholarly article | Q13442814 |
| P50 | author | Andreas Nerlich | Q58668367 |
| Erwin Schleicher | Q106827268 | ||
| P2093 | author name string | Wagner E | |
| P2860 | cites work | Accelerated age-related browning of human collagen in diabetes mellitus | Q24597835 |
| Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM | Q28190199 | ||
| Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline | Q28319359 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. | Q34111608 | ||
| Advanced glycosylation: chemistry, biology, and implications for diabetes and aging | Q34351918 | ||
| Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process | Q34663994 | ||
| Accumulation of Maillard reaction products in skin collagen in diabetes and aging | Q35610341 | ||
| Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus | Q35610369 | ||
| Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody | Q35798371 | ||
| Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions | Q35831145 | ||
| Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus | Q35833696 | ||
| Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose | Q36258907 | ||
| High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules | Q37529086 | ||
| Role of oxidative stress in development of complications in diabetes | Q37681089 | ||
| Non-enzymatic glycosylation and the chronic complications of diabetes: an overview | Q40174960 | ||
| Non-enzymatic glycosylation of skin collagen in patients with type 1 (insulin-dependent) diabetes mellitus and limited joint mobility | Q41496126 | ||
| Role of oxygen in cross-linking and chemical modification of collagen by glucose | Q41855170 | ||
| N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction | Q42555798 | ||
| Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine. | Q43928203 | ||
| Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits | Q45252141 | ||
| Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein. | Q65588879 | ||
| Immunochemical detection of advanced glycosylation end products in vivo | Q67895447 | ||
| Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen | Q67983052 | ||
| Effect of diabetes and aging on carboxymethyllysine levels in human urine | Q67983154 | ||
| Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitus | Q68809958 | ||
| Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins | Q69265702 | ||
| Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions | Q69466081 | ||
| Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications | Q69568881 | ||
| Kinetic analysis of glycation as a tool for assessing the half-life of proteins | Q69637185 | ||
| Relation between complications of type I diabetes mellitus and collagen-linked fluorescence | Q70006752 | ||
| Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure | Q70141654 | ||
| Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat | Q70721733 | ||
| The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions | Q71070390 | ||
| Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins | Q71542678 | ||
| epsilon-Amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus | Q71634374 | ||
| Pathways of Formation of Glycoxidation Products during Glycation of Collagen | Q71786493 | ||
| N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins | Q72030217 | ||
| Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation | Q72189944 | ||
| Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction | Q72387391 | ||
| Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane | Q72616686 | ||
| Detection of an advanced glycosylation product bound to protein in situ | Q93575718 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 457-468 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging | |
| P478 | volume | 99 |
| Q36746035 | A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population |
| Q28365449 | A comparison of left ventricular abnormalities associated with glucose intolerance in African Caribbeans and Europeans in the UK |
| Q46886008 | A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid |
| Q84569518 | A race for RAGE ligands |
| Q37326771 | AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis. |
| Q38213275 | AGEs and chronic subclinical inflammation in diabetes: disorders of immune system |
| Q38116590 | AGEs, contributors to placental bed vascular changes leading to preeclampsia |
| Q53542852 | Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. |
| Q50078700 | Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium. |
| Q50058403 | Accumulation of carboxymethyl-lysine (CML) in human cortical bone. |
| Q43664495 | Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine |
| Q91900851 | Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System |
| Q28591845 | Advanced glycated end-products affect HIF-transcriptional activity in renal cells |
| Q37520014 | Advanced glycation end products (AGE) and diabetes: cause, effect, or both? |
| Q36069797 | Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation |
| Q38193463 | Advanced glycation end products and diabetic retinopathy |
| Q35255473 | Advanced glycation end products and oxidative stress in type 2 diabetes mellitus |
| Q33563689 | Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. |
| Q37088388 | Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women |
| Q35647771 | Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice. |
| Q46105903 | Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2. |
| Q46173195 | Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes. |
| Q77333761 | Advanced glycation end products induce crosslinking of collagen in vitro |
| Q36974285 | Advanced glycation end products, diabetes and ageing. |
| Q36643573 | Advanced glycation end products: Key players in skin aging? |
| Q38081119 | Advanced glycation end products: role in pathology of diabetic cardiomyopathy |
| Q28569771 | Advanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with aging |
| Q37006353 | Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications |
| Q37831838 | Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome |
| Q35907814 | Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease |
| Q38383477 | Age- and sun exposure-dependent differences in 8-hydroxy-2'-deoxyguanosine and N-(carboxymethyl)lysine in human epidermis. |
| Q36030537 | Age-related changes in the hepatic microcirculation in mice |
| Q33817287 | Age-related muscle dysfunction |
| Q35409645 | Age-related vascular stiffening: causes and consequences. |
| Q35133201 | Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE). |
| Q40346041 | Amelioration of oxidant stress by the defensin lysozyme |
| Q47688022 | Analysis of advanced glycation end products (AGEs) in dentine: useful for age estimation? |
| Q36610126 | Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice |
| Q51144063 | Anti-prediabetic effect of rose hip (Rosa canina) extract in spontaneously diabetic Torii rats. |
| Q34067128 | Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm |
| Q36962549 | Antioxidant Activity of Tocotrienol Rich Fraction Prevents Fenitrothion-induced Renal Damage in Rats |
| Q40428494 | Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum. |
| Q35087554 | Antioxidant vitamins and their influence in diabetes mellitus |
| Q58128334 | Assessing and Advancing Technology for the Noninvasive Measurement of Clinical Glucose |
| Q47557029 | Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population. |
| Q92466356 | Associations of Handgrip Strength with Prevalence of Rheumatoid Arthritis and Diabetes Mellitus in Older Adults |
| Q60651864 | Author reply |
| Q40558928 | Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products |
| Q33836495 | Biology of renal aging in humans. |
| Q41893958 | Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. |
| Q57490035 | Cardiovascular Effects and Benefits of Exercise |
| Q36955390 | Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. |
| Q38502595 | Cell Interactions with Vascular Regenerative MAA-Based Materials in the Context of Wound Healing |
| Q48109207 | Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress |
| Q43773182 | Chronic estradiol treatment attenuates stiffening, glycoxidation, and permeability in rat carotid arteries. |
| Q42171678 | Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy |
| Q36735682 | Clinical study of advanced glycation end products in egyptian diabetic obese and non-obese patients |
| Q42120056 | Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence. |
| Q36335124 | Continuous Glucose Monitoring Systems: A Review |
| Q28168105 | Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins |
| Q92866675 | Costameres, dense plaques and podosomes: the cell matrix adhesions in cardiovascular mechanosensing |
| Q38115020 | Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy? |
| Q37694160 | DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. |
| Q40719520 | Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1. |
| Q40999553 | Defects in Vascular Mechanics Due to Aging in Rats: Studies on Arterial Wave Properties from a Single Aortic Pressure Pulse. |
| Q46575786 | Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. |
| Q41886296 | Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients |
| Q45091121 | Determinants of aortic stiffening in elderly subjects: results of a nine-year follow-up |
| Q46471398 | Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice. |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q41383829 | Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice |
| Q37643173 | Diabetes, oxidative stress and physical exercise |
| Q44631164 | Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats |
| Q35670859 | Dietary advanced glycation end products and aging |
| Q60301079 | Dietary advanced glycation end-product consumption leads to mechanical stiffening of murine intervertebral discs |
| Q84784692 | Different role of advanced glycation end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2 |
| Q33831129 | Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells |
| Q88119320 | Digestibility of Bovine Serum Albumin and Peptidomics of the Digests: Effect of Glycation Derived from α-Dicarbonyl Compounds |
| Q42712462 | Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice |
| Q41490204 | Effect of advanced glycation end products on the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor proteins in RF/6A cells. |
| Q78109086 | Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats |
| Q33766111 | Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats |
| Q36596877 | Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients |
| Q28213381 | Effects of radiation damage on intestinal morphology |
| Q37300130 | Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women |
| Q44982597 | Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema |
| Q46092121 | Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction |
| Q100512499 | Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy |
| Q54126440 | Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. |
| Q50861187 | Eucommia ulmoides extracts prevent the formation of advanced glycation end products. |
| Q39460273 | Evaluating the toxic and beneficial effects of jering beans (Archidendron jiringa) in normal and diabetic rats. |
| Q44410808 | Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice. |
| Q35014360 | Expression of advanced glycation end-products on sun-exposed and non-exposed cutaneous sites during the ageing process in humans |
| Q37206700 | Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study |
| Q41683128 | Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease. |
| Q40673270 | Genotoxicity of advanced glycation end products in mammalian cells |
| Q50226470 | Glutathione protects human nucleus pulposus cells from cell apoptosis and inhibition of matrix synthesis |
| Q46969687 | Glycated type 1 collagen induces endothelial dysfunction in culture |
| Q39649360 | Glycation of Liver Cystatin: Implication on its Structure and Function |
| Q40137109 | Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages |
| Q45231085 | Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells |
| Q34286094 | Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update |
| Q33864190 | Glycochelates and the etiology of diabetic peripheral neuropathy |
| Q35141623 | Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction |
| Q46958365 | Glycoxidative damage to human DNA: Neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes |
| Q42527191 | Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells |
| Q51032252 | Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. |
| Q46925426 | Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway |
| Q60308806 | Gold Nanoparticle-Based Detection of Low Molecular Weight AGEs from In Vitro Glycated Haemoglobin A0 Samples |
| Q39549971 | Heat treatment of Brussels sprouts retains their ability to induce detoxification enzyme expression in vitro and in vivo |
| Q37043257 | Hepatic disposal of advanced glycation end products during maturation and aging. |
| Q41984177 | High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients |
| Q40319157 | Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins. |
| Q35640767 | Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel |
| Q47727295 | Hydrogen peroxide induces programmed necrosis in rat nucleus pulposus cells through the RIP1/RIP3-PARP-AIF pathway |
| Q33688582 | Hyperglycemia impairs proteasome function by methylglyoxal |
| Q35551659 | Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis |
| Q31431805 | Immunochemical detection of imidazolone in uremia and rheumatoid arthritis |
| Q39368611 | Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention. |
| Q53598606 | Impaired glyoxalase activity is associated with reduced expression of neurotrophic factors and pro-inflammatory processes in diabetic skin cells. |
| Q46639089 | Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine |
| Q44340919 | Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). |
| Q73901906 | In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques |
| Q46602167 | Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy |
| Q37673039 | Increased levels of circulating advanced glycation end-products in menopausal women with osteoporosis |
| Q47108643 | Increased susceptibility of post-weaning rats on high-fat diet to metabolic syndrome. |
| Q40851351 | Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. |
| Q35027956 | Influence of aminoguanidine on parameters of liver injury and regeneration induced in rats by a necrogenic dose of thioacetamide |
| Q44573862 | Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative |
| Q38563967 | Inhibitory effects and actions of pentacyclic triterpenes upon glycation |
| Q92730289 | Ion channels and transporters in diabetic kidney disease |
| Q33819035 | Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase |
| Q37913979 | Kidney aging--inevitable or preventable? |
| Q37221229 | Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria |
| Q34700154 | Life and death: metabolic rate, membrane composition, and life span of animals. |
| Q37961883 | Lipids and diabetic retinopathy |
| Q24558912 | Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily |
| Q43862536 | Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. |
| Q92719259 | Mechanical damage characterization in human femoropopliteal arteries of different ages |
| Q92003068 | Metabolomic Analysis of Skeletal Muscle in Aged Mice |
| Q38197343 | Methylglyoxal and glyoxalase I in atherosclerosis |
| Q36036405 | Methylglyoxal-derived hydroimidazolone residue of plasma protein can behave as a predictor of prediabetes in Spontaneously Diabetic Torii rats. |
| Q43427774 | Mitochondrial bioenergetics, mass, and morphology are altered in cells of the degenerating human annulus |
| Q34614591 | Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. |
| Q38096444 | Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. |
| Q41447919 | Multiple protective mechanisms of alpha-lipoic acid in oxidation, apoptosis and inflammation against hydrogen peroxide induced toxicity in human lymphocytes |
| Q34006268 | Myeloperoxidase-generated oxidants and atherosclerosis |
| Q44357475 | N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. |
| Q37036184 | N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. |
| Q34003012 | NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy |
| Q35865399 | Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. |
| Q38363926 | Nepsilon-(Carboxymethyl)lysine induces gamma-glutamylcysteine synthetase in RAW264.7 cells |
| Q33181556 | Neurotoxicity of advanced glycation end-products for cultured cortical neurons |
| Q89498915 | Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis |
| Q73831601 | Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility |
| Q91251169 | Nrf2 in aging - Focus on the cardiovascular system |
| Q34107235 | Oxidant stress in the vasculature |
| Q90070032 | Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology |
| Q37003803 | Oxidative Stress in Diabetic Nephropathy |
| Q36259336 | Oxidative stress and cellular stress response in diabetic nephropathy. |
| Q36203957 | Oxidative stress and neurodegeneration |
| Q37212837 | Oxidative stress increases the risk of pancreatic β cell damage in chronic renal hypertensive rats |
| Q36891939 | Oxidative stress, AGE, and atherosclerosis |
| Q35583145 | Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation |
| Q44260190 | Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia |
| Q104486526 | Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers |
| Q48337245 | Perspective: The Paradox in Dietary Advanced Glycation End Products Research-The Source of the Serum and Urinary Advanced Glycation End Products Is the Intestines, Not the Food |
| Q37445850 | Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults |
| Q35607249 | Posttranslationally modified proteins as mediators of sustained intestinal inflammation |
| Q37061417 | Potential biomarkers of ageing. |
| Q35539571 | Prenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats. |
| Q48930767 | Prevention of age-induced N(ε)-(carboxymethyl)lysine accumulation in the microvasculature |
| Q37695163 | Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography |
| Q35557353 | Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration |
| Q47161191 | Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction. |
| Q41113178 | Protective Effects of the Mushroom Lactarius deterrimus Extract on Systemic Oxidative Stress and Pancreatic Islets in Streptozotocin-Induced Diabetic Rats |
| Q39502761 | Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. |
| Q33215830 | Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats |
| Q28281856 | Protein homeostasis: live long, won't prosper |
| Q34348802 | Protein oxidation and ageing |
| Q39619610 | Quantitative assessment of organ distribution of dietary protein-bound (13) C-labeled N(ɛ) -carboxymethyllysine after a chronic oral exposure in mice |
| Q36320548 | RAGE and its ligands: a lasting memory in diabetic complications? |
| Q36756482 | RAGE and modulation of ischemic injury in the diabetic myocardium |
| Q42263637 | RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy |
| Q42070405 | RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. |
| Q37723678 | ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration |
| Q34455919 | Reactive oxygen intermediates involved in cellular regulation |
| Q38290480 | Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages |
| Q36203962 | Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis |
| Q35221896 | Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. |
| Q37400729 | Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue |
| Q40541205 | Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide |
| Q37586657 | Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome |
| Q39365210 | Relation of glycated hemoglobin with carotid atherosclerosis in ischemic stroke patients: An observational study in Indian population |
| Q46595565 | Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition |
| Q46297919 | Repeated Oral Exposure to N ε-Carboxymethyllysine, a Maillard Reaction Product, Alleviates Gut Microbiota Dysbiosis in Colitic Mice |
| Q79888640 | Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model |
| Q54110987 | Reversing age-associated arterial dysfunction: insight from preclinical models. |
| Q36320068 | Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus. |
| Q36574142 | Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. |
| Q27003423 | Role of advanced glycation end products in cellular signaling |
| Q40394758 | Role of glucoxidation and lipid oxidation in the development of atherosclerosis. |
| Q57150277 | Serum 25-hydroxyvitamin D is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: The Rotterdam Study |
| Q33691339 | Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging |
| Q35690158 | Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults |
| Q34885399 | Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults |
| Q34213760 | Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study |
| Q28271097 | Simple non-invasive assessment of advanced glycation endproduct accumulation |
| Q46613148 | Simple noninvasive measurement of skin autofluorescence |
| Q58761326 | Sirtuin 3-dependent mitochondrial redox homeostasis protects against AGEs-induced intervertebral disc degeneration |
| Q26865565 | Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes |
| Q53752730 | Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients. |
| Q35042632 | Skin advanced glycation end product accumulation and muscle strength among adult men. |
| Q37022709 | Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes |
| Q61845347 | Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation |
| Q51620241 | Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population. |
| Q90859382 | Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness |
| Q35747582 | Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo |
| Q46844255 | Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function |
| Q47094524 | The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases |
| Q40014211 | The Natural Polyphenol Epigallocatechin Gallate Protects Intervertebral Disc Cells from Oxidative Stress |
| Q36132723 | The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation |
| Q52313112 | The Role of Free Radicals in Autophagy Regulation: Implications for Ageing. |
| Q77682694 | The aging kidney |
| Q41729219 | The association between the RAGE G82S polymorphism, sRAGE and chronic periodontitis in Taiwanese individuals with and without diabetes. |
| Q48359381 | The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS). |
| Q51281402 | The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus. |
| Q41742267 | The glucose/insulin system and vitamin C: implications in insulin-dependent diabetes mellitus |
| Q39794529 | The influence of sublethal blue light exposure on human RPE cells. |
| Q77530330 | The liver is the main site for metabolism of circulating advanced glycation end products |
| Q33853348 | The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation |
| Q35649410 | The role of advanced glycation end products in the development of atherosclerosis |
| Q90589122 | The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker? |
| Q37902643 | Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease |
| Q36184043 | Treadmill Exercise Attenuates Retinal Oxidative Stress in Naturally-Aged Mice: An Immunohistochemical Study |
| Q38134924 | Unlocking the biology of RAGE in diabetic microvascular complications |
| Q80795292 | Urinary excretion of fluorescent advanced glycation end products (AGEs) in the elderly |
| Q37212344 | Use of human vascular tissue microarrays for measurement of advanced glycation endproducts |
| Q36124536 | Views from within and beyond: narratives of cardiac contractile dysfunction under senescence |
| Q54004598 | [Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives] |
| Q30318169 | [Protein glycation as a pathological mechanism in diabetes]. |
| Q28364478 | p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice |
Search more.